Miguel Guzmán-Rivero2026-03-222026-03-22202310.32388/jkz848https://doi.org/10.32388/jkz848https://andeanlibrary.org/handle/123456789/86991Potential competing interests: No potential competing interests to declareenCoronavirus disease 2019 (COVID-19)Nicotinic acetylcholine receptorAcetylcholine receptorAcetylcholineKey (lock)Nicotinic agonist2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorChemistryReview of: "The α7 Nicotinic Acetylcholine Receptor: a Key Molecule in Post-COVID Syndrome?"peer-review